What is the Impact of New Developments in Breast Cancer Care and Treatment on Indian Patients?
Breast cancer has surpassed lung cancer as the most frequently diagnosed cancer globally. In India, it is the most common cancer among women, with over 100,000 new cases diagnosed annually. Early detection and advancements in treatment have significantly improved survival rates and quality of life for patients.
Advancements in Breast Cancer Diagnosis
- PET-CT Imaging: Positron Emission Tomography-Computed Tomography (PET-CT) has enhanced the accuracy of staging and detecting metastases in breast cancer patients.
- OncoStem Diagnostics' CanAssist Breast: This molecular test, developed specifically for Indian patients, predicts the risk of recurrence by analyzing clinical parameters and biomarkers. It helps determine the necessity of chemotherapy, sparing low-risk patients from unnecessary treatment.
Innovations in Breast Cancer Treatment
- HER2-Directed Therapies: Targeted treatments for HER2-positive breast cancer have significantly improved outcomes, reducing recurrence rates in both early and advanced stages.
- Bone-Targeted Medications: New drugs have been developed to prevent the spread of cancer to the bones, a common site for metastasis in breast cancer patients.
Impact on Indian Patients
These advancements have led to:
- Improved survival rates due to early detection and personalized treatment plans.
- Reduced side effects and better quality of life through targeted therapies.
- Increased accessibility to advanced diagnostic tools and treatments in urban and rural areas.
For more detailed information, visit What is the Impact of New Developments in Breast Cancer Care and Treatment on Indian Patients?.